allergic asthma
In a       three-parallel-dose group, double-blind, placebo-controlled, randomized,       crossover study, with a washout period of 3 to 8 wk, a total of 29 patients with        mild to moderate allergic asthma underwent AMP challenge and sputum induction       before and after 14 d of treatment with ciclesonide or matched placebo.
In a       three-parallel-dose group, double-blind, placebo-controlled, randomized,       crossover study, with a washout period of 3 to 8 wk, a total of 29  @OBJECT$   @PREDICAT$         mild to moderate  @SUBJECT$  underwent AMP challenge and sputum induction       before and after 14 d of treatment with ciclesonide or matched placebo.